Merck&Co earnings, Revenue beat in Q3

  • Investing.com
  • Stock Market News
Merck&Co earnings, Revenue beat in Q3
Credit: © Reuters.

Investing.com - Merck (NS: PROR )&Co reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Merck&Co announced earnings per share of $1.85 on revenue of $15.00. Analysts polled by Investing.com anticipated EPS of $1.75 on revenue of $14.07B.

Merck&Co shares are down 4% from the beginning of the year and are trading at $100.75 , down-from-52-week-high.

Merck&Co follows other major Healthcare sector earnings this month

Merck&Co's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.

J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles